Ann: GVHD Day 28 Results Presentation, page-61

Maybe you didn't read my post in full, these are based on Mesoblast capturing the entire market. Obviously this won't happen, nor would you expect Mesoblast to be able to achieve anything of the sort from day 1.

We still don't know if Mesoblast will take this to market on its own or partner it ... so that decision will determine what margins/costs are involved, but at peak sales your back on the envelope calculations are sound.

FDA approval does appear to have spurred on some promising activities e.g. manufacturing in Singapore is ramping up to prepare stock to enter into the Canadian market (off the back of successful phase 3 results).

But of course you will want to see the revenue flow through the door first before you invest ... that day will come!